United States (US) Blood Clotting Factor Market (2025-2031) | Competitive Landscape, Growth, Segmentation, Companies, Size & Revenue, Industry, Value, Share, Outlook, Analysis, Trends, Forecast
Market Forecast By Product (Clinical Laboratory Analysers, Point-Of-Care Testing Analysers), By Test (Prothrombin Time Testing, Fibrinogen Testing, Activated Partial Thromboplastin Time Testing, Activated Clotting Time Testing, D-Dimer Testing, Platelet Function Tests, Anti-Factor Xa Tests, Heparin and Protamine Dose Response Tests for ACT), By Technology (Mechanical Technology, Optical Technology, Electrochemical Technology, Others), By Application (Bleeding Disorders, Acquired Bleeding Disorders, Von Willebrand Disease, Haemophilia), By End User (Academic Institutions, Hospitals, Diagnostic Laboratories, Others) And Competitive Landscape
| Product Code: ETC9961010 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Key Highlights of the Report:
- United States (US) Blood Clotting Factor Market Outlook
- Market Size of United States (US) Blood Clotting Factor Market, 2024
- Forecast of United States (US) Blood Clotting Factor Market, 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Revenues & Volume for the Period 2021- 2031
- United States (US) Blood Clotting Factor Market Trend Evolution
- United States (US) Blood Clotting Factor Market Drivers and Challenges
- United States (US) Blood Clotting Factor Price Trends
- United States (US) Blood Clotting Factor Porter's Five Forces
- United States (US) Blood Clotting Factor Industry Life Cycle
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Product for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Clinical Laboratory Analysers for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Point-Of-Care Testing Analysers for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Test for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Prothrombin Time Testing for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Fibrinogen Testing for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Activated Partial Thromboplastin Time Testing for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Activated Clotting Time Testing for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By D-Dimer Testing for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Platelet Function Tests for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Anti-Factor Xa Tests for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Heparin and Protamine Dose Response Tests for ACT for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Technology for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Mechanical Technology for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Optical Technology for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Electrochemical Technology for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Application for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Bleeding Disorders for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Acquired Bleeding Disorders for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Von Willebrand Disease for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Haemophilia for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By End User for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Academic Institutions for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Hospitals for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Diagnostic Laboratories for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Blood Clotting Factor Market Revenues & Volume By Others for the Period 2021- 2031
- United States (US) Blood Clotting Factor Import Export Trade Statistics
- Market Opportunity Assessment By Product
- Market Opportunity Assessment By Test
- Market Opportunity Assessment By Technology
- Market Opportunity Assessment By Application
- Market Opportunity Assessment By End User
- United States (US) Blood Clotting Factor Top Companies Market Share
- United States (US) Blood Clotting Factor Competitive Benchmarking By Technical and Operational Parameters
- United States (US) Blood Clotting Factor Company Profiles
- United States (US) Blood Clotting Factor Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6Wresearch actively monitors the United States (US) Blood Clotting Factor Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Blood Clotting Factor Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Blood Clotting Factor Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Blood Clotting Factor Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Blood Clotting Factor Market - Industry Life Cycle |
3.4 United States (US) Blood Clotting Factor Market - Porter's Five Forces |
3.5 United States (US) Blood Clotting Factor Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Blood Clotting Factor Market Revenues & Volume Share, By Test, 2021 & 2031F |
3.7 United States (US) Blood Clotting Factor Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 United States (US) Blood Clotting Factor Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 United States (US) Blood Clotting Factor Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Blood Clotting Factor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bleeding disorders in the United States |
4.2.2 Growing awareness about the treatment of hemophilia and other clotting disorders |
4.2.3 Technological advancements in the development of blood clotting factor products |
4.3 Market Restraints |
4.3.1 High cost associated with blood clotting factor treatments |
4.3.2 Stringent regulatory requirements for the approval of new products |
4.3.3 Limited accessibility to treatment in certain regions of the United States |
5 United States (US) Blood Clotting Factor Market Trends |
6 United States (US) Blood Clotting Factor Market, By Types |
6.1 United States (US) Blood Clotting Factor Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Blood Clotting Factor Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Blood Clotting Factor Market Revenues & Volume, By Clinical Laboratory Analysers, 2021- 2031F |
6.1.4 United States (US) Blood Clotting Factor Market Revenues & Volume, By Point-Of-Care Testing Analysers, 2021- 2031F |
6.2 United States (US) Blood Clotting Factor Market, By Test |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Blood Clotting Factor Market Revenues & Volume, By Prothrombin Time Testing, 2021- 2031F |
6.2.3 United States (US) Blood Clotting Factor Market Revenues & Volume, By Fibrinogen Testing, 2021- 2031F |
6.2.4 United States (US) Blood Clotting Factor Market Revenues & Volume, By Activated Partial Thromboplastin Time Testing, 2021- 2031F |
6.2.5 United States (US) Blood Clotting Factor Market Revenues & Volume, By Activated Clotting Time Testing, 2021- 2031F |
6.2.6 United States (US) Blood Clotting Factor Market Revenues & Volume, By D-Dimer Testing, 2021- 2031F |
6.2.7 United States (US) Blood Clotting Factor Market Revenues & Volume, By Platelet Function Tests, 2021- 2031F |
6.2.8 United States (US) Blood Clotting Factor Market Revenues & Volume, By Heparin and Protamine Dose Response Tests for ACT, 2021- 2031F |
6.2.9 United States (US) Blood Clotting Factor Market Revenues & Volume, By Heparin and Protamine Dose Response Tests for ACT, 2021- 2031F |
6.3 United States (US) Blood Clotting Factor Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Blood Clotting Factor Market Revenues & Volume, By Mechanical Technology, 2021- 2031F |
6.3.3 United States (US) Blood Clotting Factor Market Revenues & Volume, By Optical Technology, 2021- 2031F |
6.3.4 United States (US) Blood Clotting Factor Market Revenues & Volume, By Electrochemical Technology, 2021- 2031F |
6.3.5 United States (US) Blood Clotting Factor Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Blood Clotting Factor Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Blood Clotting Factor Market Revenues & Volume, By Bleeding Disorders, 2021- 2031F |
6.4.3 United States (US) Blood Clotting Factor Market Revenues & Volume, By Acquired Bleeding Disorders, 2021- 2031F |
6.4.4 United States (US) Blood Clotting Factor Market Revenues & Volume, By Von Willebrand Disease, 2021- 2031F |
6.4.5 United States (US) Blood Clotting Factor Market Revenues & Volume, By Haemophilia, 2021- 2031F |
6.5 United States (US) Blood Clotting Factor Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Blood Clotting Factor Market Revenues & Volume, By Academic Institutions, 2021- 2031F |
6.5.3 United States (US) Blood Clotting Factor Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 United States (US) Blood Clotting Factor Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.5.5 United States (US) Blood Clotting Factor Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Blood Clotting Factor Market Import-Export Trade Statistics |
7.1 United States (US) Blood Clotting Factor Market Export to Major Countries |
7.2 United States (US) Blood Clotting Factor Market Imports from Major Countries |
8 United States (US) Blood Clotting Factor Market Key Performance Indicators |
8.1 Patient adherence to prescribed treatment plans |
8.2 Rate of adoption of novel blood clotting factor therapies |
8.3 Average time from diagnosis to initiation of treatment |
9 United States (US) Blood Clotting Factor Market - Opportunity Assessment |
9.1 United States (US) Blood Clotting Factor Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Blood Clotting Factor Market Opportunity Assessment, By Test, 2021 & 2031F |
9.3 United States (US) Blood Clotting Factor Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 United States (US) Blood Clotting Factor Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 United States (US) Blood Clotting Factor Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Blood Clotting Factor Market - Competitive Landscape |
10.1 United States (US) Blood Clotting Factor Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Blood Clotting Factor Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Global Go To Market Strategy - 2030
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here
Request Primary Research & Report
- Single User License$ 1,995
- Department License$ 2,400
- Site License$ 3,120
- Global License$ 3,795
Leadership Perspectives from Industry Events
Search
6Wresearch in the News
Forbes
Citing 6Wresearch analytics to map global infrastructure and pharmaceutical industry trajectories.
Bloomberg Law
Direct syndication of 6Wresearch's macro data points, capturing complex supply chain shifts.
Reuters
Tracking industrial manufacturing adjustments and electronic security ecosystem scaling.
Mint
Utilizing deep-tech sector market sizing to analyze global automation and robotics.
The Economic Times
Anchoring features on industrial IoT growth metrics and connected smart-grid devices.
Business Standard
Featuring strategic evaluations of Advanced Driver Assistance Systems (ADAS) and AI road safety.
The Hindu
Spotlighting core commercial metrics ranging from unmanned aerial vehicles (UAVs) to consumer durables.
Financial Express
Anchoring quarterly reviews on cross-border real estate tech and structural hardware manufacturing.
Yahoo Finance
Syndicating the tracker's $30.1 billion untapped-market findings, spotlighting Japan, the US and China as India's top new-potential importers.
India Today
Carrying the release on smartphones leading India's export potential to $94 billion by 2031, per 6WExportGTM data.
Dailyhunt
Distributing the tracker findings to its regional readership, framing India's export diversification into Japan and Mexico.
PR Newswire Original release
Publishing the full India Export Attractiveness Tracker 2026, detailing new trade corridors across iron ore, LCVs and pharmaceuticals.
The Industrial
Highlighting the tracker's read on India's semiconductor ambitions and long-term chip-assembly export potential.
PTI News
Reporting on the $66.81 billion pharmaceuticals export opportunity flagged in the tracker, amid looming US generic-drug tariffs.
Tribune India
Covering the tracker's tariff-versus-regulation analysis across India's mature export markets in the US, China and UAE.
ANI News
Amplifying the report's findings on polished diamonds, refined petroleum and medicines as India's core export engines.
International Business Magazine
Covering the report's insight into how AEB, blind spot detection, and driver monitoring are reshaping India's ADAS market.
Focus Gaming News
Highlighting the research forecast for Egypt's gambling market, projecting steady growth through 2032.
Thought Leadership and Analyst Meet
Our Clients
Latest Reports
- Namibia Financial Asset Management Market (2026-2032)
- Mozambique Financial Asset Management Market (2026-2032)
- Montenegro Financial Asset Management Market (2026-2032)
- Mongolia Financial Asset Management Market (2026-2032)
- Monaco Financial Asset Management Market (2026-2032)
- Micronesia Financial Asset Management Market (2026-2032)
- Mauritius Financial Asset Management Market (2026-2032)
- Mauritania Financial Asset Management Market (2026-2032)
- Marshall Islands Financial Asset Management Market (2026-2032)
- Malta Financial Asset Management Market (2026-2032)
Industry Events and Analyst Meet
EV India Expo 2026
HIMTEX 2026
India Refining Summit 2026
India EV Show 2026
EV tech India Expo 2026
Whitepaper
- Middle East & Africa Commercial Security Market Click here to view more.
- Middle East & Africa Fire Safety Systems & Equipment Market Click here to view more.
- GCC Drone Market Click here to view more.
- Middle East Lighting Fixture Market Click here to view more.
- GCC Physical & Perimeter Security Market Click here to view more.
